[Modification of B-cell precursor frequencies by systemic photochemotherapy (PUVA) in patients with systemic scleroderma].
Kunzelmann
V
V
Dermatologische Klinik und Poliklinik, Universitätsklinikum Charité, Humboldt-Universität zu Berlin.
Brenke
A
A
Fetscher
I
I
Lukowsky
A
A
Leschik
G
G
Adrian
K
K
Sönnichsen
N
N
D001323:Autoantibodies / Q000032:analysis; D016175:B-Lymphocyte Subsets / Q000187:drug effects* / Q000276:immunology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D018655:Lymphocyte Count / Q000187:drug effects; D011701:PUVA Therapy; D010865:Pilot Projects; D011928:Raynaud Disease / Q000188:drug therapy / Q000276:immunology; D012595:Scleroderma, Systemic / Q000188:drug therapy* / Q000276:immunology; D012881:Skin Temperature / Q000187:drug effects
D001323:Autoantibodies; D007074:Immunoglobulin G; D007075:Immunoglobulin M
Beeinflussung von B-Zellpräkursorfrequenzen durch systemische Photochemotherapie (PUVA) bei Patienten mit systemischer Sklerodermie.